Original version Date: 22/06/2020
|
Author: NeoMed Consensus Group
|
Current Version number: 1.1
|
Current Version Date: November 2020
|
Risk Rating: Low
|
Due for Review: November 2025
|
Approval by: DTC
|
Approval Date:
|
Ampicillin |
Revision Date : 26-2-2021
|
Approved : TC, KOH
|
Alert
The Antimicrobial Stewardship Team recommends this drug is listed under the following category: Unrestricted.
Indication
Directed treatment of infections caused by susceptible gram positive (including Streptococcus species, Enterococcus faecalis and Listeria monocytogenes) and susceptible gram-negative bacteria (some strains of Escherichia coli, many strains of Haemophilus influenzae, Neisseria meningitidis, Proteus mirabilis and Salmonellae).
Empiric treatment of suspected early onset sepsis including meningitis, with an aminoglycoside.
Action
Bactericidal - inhibits the synthesis of the bacterial cell wall. Ampicillin is hydrolysed by beta-lactamases and therefore not effective against penicillinase producing bacteria.
Drug Type
Antibacterial - Penicillin
Trade Name
Ampicyn, Austrapen, Ibimicyn
Presentation
Ampicillin 500 mg vial
Ampicillin 1000 mg vial
|
